Read + Share
Liu M, Xia S, Zhang X, Zhang B, et al. Development and validation of a blood-based genomic mutation signature to predict
the clinical outcomes of atezolizumab therapy in NSCLC. Lung Cancer 2022;170:148-155.
PMID: 35792434
|
 |
|
Liu M, Xia S, Zhang X, Zhang B, et al. Development and validation of a blood-based genomic mutation signature to predict
the clinical outcomes of atezolizumab therapy in NSCLC. Lung Cancer 2022;170:148-155.
PMID: 35792434
|
|
|
|